|
1
|
Boller S, Joblin BA, Xu L, et al: From
signal transduction to signal interpretation: an alternative model
for the molecular function of insulin receptor substrates. Arch
Physiol Biochem. 118:148–155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
White MF: IRS proteins and the common path
to diabetes. Am J Physiol Endocrinol Metab. 283:E413–E422.
2002.PubMed/NCBI
|
|
3
|
Tamemoto H, Kadowaki T, Tobe K, et al:
Insulin resistance and growth retardation in mice lacking insulin
receptor substrate-1. Nature. 372:182–186. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Draznin B: Molecular mechanisms of insulin
resistance: serine phosphorylation of insulin receptor substrate-1
and increased expression of p85alpha: the two sides of a coin.
Diabetes. 55:2392–2397. 2006. View Article : Google Scholar
|
|
5
|
Gual P, Le Marchand-Brustel Y and Tanti
JF: Positive and negative regulation of insulin signaling through
IRS-1 phosphorylation. Biochimie. 87:99–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee AV, Gooch JL, Oesterreich S, Guler RL
and Yee D: Insulin-like growth factor I-induced degradation of
insulin receptor substrate 1 is mediated by the 26S proteasome and
blocked by phosphatidylinositol 3′-kinase inhibition. Mol Cell
Biol. 20:1489–1496. 2000.PubMed/NCBI
|
|
7
|
Chen W, Xia YP, Chen WJ, Yu MH, Li YM and
Ye HY: Improvement of myocardial glycolipid metabolic disorder in
diabetic hamster with Astragalus polysaccharides treatment.
Mol Biol Rep. 39:7609–7615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang N, Zhang D, Mao X, Zou F, Jin H and
Ouyang J: Astragalus polysaccharides decreased the
expression of PTP1B through relieving ER stress induced activation
of ATF6 in a rat model of type 2 diabetes. Mol Cell Endocrinol.
307:89–98. 2009. View Article : Google Scholar
|
|
9
|
Kallon S, Li X, Ji J, et al:
Astragalus polysaccharide enhances immunity and inhibits
H9N2 avian influenza virus in vitro and in vivo. J Anim Sci
Biotechnol. 4:222013. View Article : Google Scholar
|
|
10
|
Lu J, Chen X, Zhang Y, et al:
Astragalus polysaccharide induces anti-inflammatory effects
dependent on AMPK activity in palmitate-treated RAW264.7 cells. Int
J Mol Med. 31:1463–1470. 2013.
|
|
11
|
Wu Y, Ou-Yang JP, Wu K, Wang Y, Zhou YF
and Wen CY: Hypoglycemic effect of Astragalus polysaccharide
and its effect on PTP1B. Acta Pharmacol Sin. 26:345–352. 2005.
|
|
12
|
Mao XQ, Wu Y, Wu K, Liu M, Zhang JF, Zou F
and Ou-Yang JP: Astragalus polysaccharide reduces hepatic
endoplasmic reticulum stress and restores glucose homeostasis in a
diabetic KKAy mouse model. Acta Pharmacol Sin. 28:1947–1956. 2007.
View Article : Google Scholar
|
|
13
|
Saltiel AR and Kahn CR: Insulin signalling
and the regulation of glucose and lipid metabolism. Nature.
414:799–806. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pessin JE and Saltiel AR: Signaling
pathways in insulin action: molecular targets of insulin
resistance. J Clin Invest. 106:165–169. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iwatsuka H, Shino A and Suzuoki Z: General
survey of diabetic features of yellow KK mice. Endocrinol Jpn.
17:23–35. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hitman GA, Hawrami K, McCarthy MI, et al:
Insulin receptor substrate-1 gene mutations in NIDDM; implications
for the study of polygenic disease. Diabetologia. 38:481–486. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
White MF: The IRS-signalling system: a
network of docking proteins that mediate insulin action. Mol Cell
Biochem. 182:3–11. 1998. View Article : Google Scholar
|
|
18
|
White MF: The IRS-signalling system in
insulin and cytokine action. Philos Trans R Soc Lond B Biol Sci.
351:181–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thirone AC, Huang C and Klip A:
Tissue-specific roles of IRS proteins in insulin signaling and
glucose transport. Trends Endocrinol Metab. 17:72–78. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kubota N, Kubota T, Itoh S, et al: Dynamic
functional relay between insulin receptor substrate 1 and 2 in
hepatic insulin signaling during fasting and feeding. Cell Metab.
8:49–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goodyear LJ, Giorgino F, Sherman LA, Carey
J, Smith RJ and Dohm GL: Insulin receptor phosphorylation, insulin
receptor substrate-1 phosphorylation, and phosphatidylinositol
3-kinase activity are decreased in intact skeletal muscle strips
from obese subjects. J Clin Invest. 95:2195–2204. 1995. View Article : Google Scholar
|
|
22
|
Björnholm M, Kawano Y, Lehtihet M and
Zierath JR: Insulin receptor substrate-1 phosphorylation and
phosphatidylinositol 3-kinase activity in skeletal muscle from
NIDDM subjects after in vivo insulin stimulation. Diabetes.
46:524–527. 1997.PubMed/NCBI
|
|
23
|
Krook A, Björnholm M, Galuska D, et al:
Characterization of signal transduction and glucose transport in
skeletal muscle from type 2 diabetic patients. Diabetes.
49:284–292. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abe H, Yamada N, Kamata K, et al:
Hypertension, hypertriglyceridemia, and impaired
endothelium-dependent vascular relaxation in mice lacking insulin
receptor substrate-1. J Clin Invest. 101:1784–1788. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Taniguchi CM, Ueki K and Kahn R:
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of
metabolism. J Clin Invest. 115:718–727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song R, Peng W, Zhang Y, et al: Central
role of E3 ubiquitin ligase MG53 in insulin resistance and
metabolic disorders. Nature. 494:375–379. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen YC, Fueger PT and Wang Z: Depletion
of PAK1 enhances ubiquitin-mediated survivin degradation in
pancreatic β-cells. Islets. 5:22–28. 2013.PubMed/NCBI
|
|
28
|
Kirk-Ballard H, Wang ZQ, Acharya P, et al:
An extract of Artemisia dracunculus L. inhibits
ubiquitin-proteasome activity and preserves skeletal muscle mass in
a murine model of diabetes. PLoS One. 8:e571122013.
|
|
29
|
Conaway RC, Brower CS and Conaway JW:
Emerging roles of ubiquitin in transcription regulation. Science.
296:1254–1258. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Muratani M and Tansey WP: How the
ubiquitin-proteasome system controls transcription. Nat Rev Mol
Cell Biol. 4:192–201. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wadosky KM and Willis MS: The story so
far: post-translational regulation of peroxisome
proliferator-activated receptors by ubiquitination and SUMOylation.
Am J Physiol Heart Circ Physiol. 302:H515–H526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han L, Wang P, Zhao G, Wang H, Wang M,
Chen J and Tong T: Upregulation of SIRT1 by 17β-estradiol depends
on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1.
Protein Cell. 4:310–321. 2013.
|
|
33
|
Kilroy G, Kirk-Ballard H, Carter LE and
Floyd ZE: The ubiquitin ligase Siah2 regulates PPARγ activity in
adipocytes. Endocrinology. 153:1206–1218. 2012.
|
|
34
|
Stravodimou A, Mazzoccoli G and
Voutsadakis IA: Peroxisome proliferator-activated receptor gamma
and regulations by the ubiquitin-proteasome system in pancreatic
cancer. PPAR Res. 2012:3674502012. View Article : Google Scholar
|
